A Randomized Trial Evaluating the Use of a Smart Water Bottle to Increase Fluid Intake in Stone Formers.


Journal

Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation
ISSN: 1532-8503
Titre abrégé: J Ren Nutr
Pays: United States
ID NLM: 9112938

Informations de publication

Date de publication:
07 2022
Historique:
received: 07 01 2021
revised: 02 06 2021
accepted: 19 07 2021
pubmed: 15 3 2022
medline: 7 7 2022
entrez: 14 3 2022
Statut: ppublish

Résumé

The aim of this study is to evaluate if the use of a smart water bottle improves urine volume in stone forming patients. Adults with nephrolithiasis and low urine volume (<1.5 L) documented on a 24-hour urinalysis (24 hr U) were randomized to receive either standard dietary recommendations to increase fluid intake (DR arm), or DR and a smart water bottle (HidrateSpark®; Hydrate Inc., Minneapolis, MN) that recorded fluid intake, synced to the user's smartphone, and provided reminders to drink (SB arm). Participants completed baseline surveys assessing barriers to hydration. They then repeated a 24 hr U and survey at 6 and 12 weeks, respectively. Eighty-five subjects (44 DR, 41 SB) were enrolled. The main baseline factor limiting fluid intake was not remembering to drink (60%). Follow-up 24 hr Us were available for 51 patients. The mean increase in volume was greater in the SB arm (1.37 L, 95% confidence interval -0.51 to 3.25) than the DR arm (0.79 L, 95% confidence interval -1.15 to 2.73) (P = .04). A smaller percentage of subjects in the SB arm reported not remembering to drink as the main factor limiting fluid intake in the follow-up questionnaire compared to baseline (45.4% vs. 68.4%, P < .05). This was not true for the DR arm (40.0% vs. 51.2%, P = .13). Difficulty remembering to drink is a barrier to achieving sufficient fluid intake in stone formers. The use of a smart bottle was associated with greater increases in 24 hr U volumes and less difficulty remembering to drink.

Identifiants

pubmed: 35283036
pii: S1051-2276(21)00184-9
doi: 10.1053/j.jrn.2021.07.007
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

389-395

Informations de copyright

Copyright © 2021 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Thomas E Stout (TE)

Department of Urology, University of Minnesota, Minneapolis, MN. Electronic address: tstout@umn.edu.

James E Lingeman (JE)

Department of Urology, Indiana School of Medicine, Indianapolis, IN.

Amy E Krambeck (AE)

Department of Urology, Indiana School of Medicine, Indianapolis, IN.

Mitchell R Humphreys (MR)

Mayo Clinic Department of Urology, Phoenix, AZ.

Anna Zisman (A)

Section of Nephrology, University of Chicago, Chicago, IL.

Sarah Elfering (S)

University of Minnesota Department of Medicine, Division of Nephrology, Minneapolis, MN.

Tim Large (T)

Department of Urology, Indiana School of Medicine, Indianapolis, IN.

Philipp Dahm (P)

Department of Urology, University of Minnesota, Minneapolis, MN.

Michael Borofsky (M)

Department of Urology, University of Minnesota, Minneapolis, MN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH